GE HealthCare Technologies Inc. (GEHC)
Should You Buy, Sell, or Hold GE Healthcare Before Q1 Earnings?
GEHC Q1 results are likely to reflect strong growth in Imaging, Ultrasound, and AI, fueled by robust procedure volumes and global partnerships despite China headwinds.
Stay Ahead of the Game With GE HealthCare (GEHC) Q1 Earnings: Wall Street's Insights on Key Metrics
Besides Wall Street's top -and-bottom-line estimates for GE HealthCare (GEHC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
Here's Why You Should Hold the GEHC Stock in Your Portfolio for Now
GE HealthCare's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
GE HealthCare (GEHC) Surges 10.6%: Is This an Indication of Further Gains?
GE HealthCare (GEHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
GE HealthCare: Looking Healthier Here
GE HealthCare, spun off from GE in early 2023, has seen its stock trade between $60-$90, now trading at the low end of the range. The company reports nearly $20 billion in sales and is gradually posting higher margins, looking to expand these to the 20% mark. For 2025, GE HealthCare expected 2-3% sales growth and a 40-50 basis point EBIT margin improvement, with free cash flow over $1.75 billion.
GEHC Stock Gains Following Buyout Completion to Boost Its PDx Arm
GE HealthCare aims to expand its existing footprint and offerings in Japan, as well as enhance patient access to next-generation radiopharmaceuticals via its latest acquisition.
GEHC Stock May Rise as Revolution Vibe CT Enhances Imaging Tech
GE HealthCare introduces Revolution Vibe CT, a cutting-edge imaging system designed to enhance diagnostic precision, improve workflow efficiency, and expand accessibility.
GE HealthCare's Latest Product Launch to Boost Cardiology Care
GEHC's latest commercial launch of Flyrcado and the grant of pass-through status by CMS aim to serve a wider patient pool across the United States.
US population is aging: here are the top 2 stocks set to benefit
The US population is aging. In fact, according to Mizuho analysts, those aged 75 and more will likely make up about 10% of the country's population by the end of this decade.
GEHC Stock Falls Despite New Launch to Boost Breast Cancer Diagnosis
GE HealthCare aims to deliver optimal outcomes with its innovative, patient-friendly and efficient AI-driven technology via its latest product offering.
Here's Why You Should Hold GEHC Stock in Your Portfolio for Now
GE HealthCare's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes
Last week, U.S. President Donald Trump vowed to impose a 25% tariff on imported goods from Mexico and Canada and to double tariffs on those from China to 20%.
